✦ LIBER ✦

Z-(±)-1-azabicyclo[2.2.1]heptan-3-one, O-(3-aryl-2-propynyl) oximes as potential m1-subtype selective muscarinic agonists

✍ Scribed by H. Tecle; J.C. Jaen; C. Augelli-Szafran; S.D. Barrett; B.W. Caprathe; D.J. Lauffer; T. Mirzadegan; W.H. Moos; D.W. Moreland; M.R. Pavia; R.D. Schwarz; A.J. Thomas; R.E. Davis

Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 298 KB
Volume: 5
Category: Article
ISSN: 0960-894X
DOI: 10.1016/0960-894x(95)00086-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

(±)-1-Azabicyclo[2.2.1]heptan-3-one, O-(

(±)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-methyl-5-aryl-2-penten-4-ynyl) oximes: Potent muscarinic agonists

✍ H. Tecle; D.J. Lauffer; R.E. Davis; T. Mirzadegan; D.W. Moreland; R.D. Schwan; A 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 279 KB

Synthesis and SAR of a new class of 1-azabicyclo[2.2.1 Jheptan3-one. 0-(3-mtthyl-5-aryl-2-penten-4-ynyl) oxime muscarinic agonists are described Depend@ on the geometry of the C=N and C=C bonds, subnanomolar potency and/or high efbcy an achkved.

Synthesis and muscarinic M3 pharmacologi

Synthesis and muscarinic M3 pharmacological activities of 1-azabicyclo[2.2.2]octan-3-one oxime derivatives

✍ Ralf Plate; Marc J.M. Plaum; Thijs de Boer; John S. Andrews 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 634 KB

A series of 1-azabicyclo[2.2.2]octan-3-one oximes and related 1-azabicyclo-[2.2.2]-octan-3-one hydroxylamines were synthesized and tested for muscarinic M3 activity. All compounds showed at least some muscarinic binding properties, however, only one member of the series demonstrated mucarinic M3 ago

4-Aryl-2-(o-hydroxymethylphenylamino)-4-

4-Aryl-2-(o-hydroxymethylphenylamino)-4-oxo-Z-2-butenoic Acids as Intermediates in the Synthesis of Z-2-Phenacylidene-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-ones.

✍ A. N. Maslivets; N. S. Kistanova; K. S. Bozdyreva; O. A. Maslivets 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 79 KB 👁 2 views

Imidazo[1,2-a]pyrazin-8-ones, Imidazo[1,

Imidazo[1,2-a]pyrazin-8-ones, Imidazo[1,2-d][1,2,4]triazin-8-ones and Imidazo[2,1-f][1,2,4]triazine-8-ones as α2/α3 Subtype Selective GABAA Agonists for the Treatment of Anxiety.

✍ Simon C. Goodacre; David J. Hallett; Robert W. Carling; Jose L. Castro; David S. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 19 KB 👁 1 views

ChemInform Abstract: Synthesis of Novel

ChemInform Abstract: Synthesis of Novel Succinamide Derivatives Having the 5,11-Dihydro-6H- pyrido(2,3-b)(1,4)benzodiazepin-6-one Skeleton as Potent and Selective M2 Muscarinic Receptor Antagonists. Part 1.

✍ T. WATANABE; I. KINOYAMA; A. KAKEFUDA; T. OKAZAKI; K. TAKIZAWA; S. HIRANO; H. SH 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 1 views

ChemInform Abstract: Synthesis of Novel

ChemInform Abstract: Synthesis of Novel Succinamide Derivatives Having a 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one Skeleton as Potent and Selective M2 Muscarinic Receptor Antagonists. Part 2.

✍ T. WATANABE; A. KAKEFUDA; I. KINOYAMA; K. TAKIZAWA; S. HIRANO; H. SHIBATA; I. YA 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 36 KB 👁 2 views

Synthesis of Novel Succinamide Derivatives Having a 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one Skeleton as Potent and Selective M 2 Muscarinic Receptor Antagonists. Part 2. -Among the screened compounds derivative (IIIe) exhibits the highest affinity for M 2 muscarinic receptors and (III